CL Verweij
- Hematology top 2%
- Platelet Disorders and Treatments 5
- Blood groups and transfusion 4
- Blood Coagulation and Thrombosis Mechanisms 3
- Immunology top 5%
- Complement system in diseases 5
- Immune Response and Inflammation 3
- Immunology and Allergy top 5%
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 7
- Systemic Lupus Erythematosus Research 5
- Genetics top 10%
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- FC BreedveldEric L. KaijzelJP GirmaJJ SixmaB. A. C. DijkmansSaskia le CessieHans PannekoekDominique Meyer
- Partner nations
- NetherlandsUnited KingdomFrance
In The Last Decade
CL Verweij
25 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 92
- Hematology 401
- Immunology 507
- Immunology and Allergy 115
- Rheumatology 226
- Genetics 101
Countries citing papers authored by CL Verweij
This map shows the geographic impact of CL Verweij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CL Verweij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CL Verweij more than expected).
Fields of papers citing papers by CL Verweij
This network shows the impact of papers produced by CL Verweij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CL Verweij. The network helps show where CL Verweij may publish in the future.
Co-authorship network
The 25 scholars most cited alongside CL Verweij, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 3 | |
| 2 | 2005 | 0 | |
| 3 | 2004 | 1 | |
| 4 | 2004 | 8 | |
| 5 | 2003 | 5 | |
| 6 | 2001 | 81 | |
| 7 | 2001 | 12 | |
| 8 | 1999 | 58 | |
| 9 | 1999 | 221 | |
| 10 | Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. | 1997 | 222 |
| 11 | Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. | 1997 | 255 |
| 12 | 1996 | 11 | |
| 13 | 1995 | 20 | |
| 14 | 1990 | 1 | |
| 15 | 1988 | 25 | |
| 16 | 1987 | 13 | |
| 17 | 1987 | 118 | |
| 18 | 1987 | 148 | |
| 19 | 1986 | 3 | |
| 20 | 1986 | 22 |
About CL Verweij
CL Verweij is a scholar working on Hematology, Rheumatology and Immunology, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Platelet Disorders and Treatments (5 papers), Complement system in diseases (5 papers), Systemic Lupus Erythematosus Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Blood groups and transfusion (4 papers), Immune Response and Inflammation (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Hematology (401 citations), Immunology (507 citations) and Immunology and Allergy (115 citations). CL Verweij has collaborated with scholars based in Netherlands, United Kingdom and France. Frequent co-authors include FC Breedveld, Eric L. Kaijzel, JP Girma, JJ Sixma, B. A. C. Dijkmans, Saskia le Cessie, Hans Pannekoek, Dominique Meyer, A Bakker and Dominique Meyer. Their work appears in journals such as Blood, Nucleic Acids Research, Genes and Immunity, Annals of the Rheumatic Diseases and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.